Obesity drugs and devices reaching the global market, 2011-2017

The past couple of years have not looked kindly on drugs in development (or on the market) for the treatment of obesity, while devices for obesity have found a more favorable regulatory and market environment.

Past is not always prologue, and this is true for the future of obesity treatments.  We have analyzed the status of product development and the specific pending regulatory approvals and market introductions separately for obesity drugs and devices and can illustrate that a shift will take place in the relative activity of these two segments of the market:

Source: MedMarket Diligence, LLC; Report #S835.

Leave a Reply